The number of probiotic products in the marketplace is on the rise, gaining momentum along 14 with the upsurge in research on the role of the human gut microbiome in health. Although such products 15 are considered safe for consumption, these probiotic supplements and beverages are not subject to 16 stringent federal regulation for quality. While only certain strains of probiotic microbes have been 17 studied for efficacy in clinical trials, the ingredient labels of commercial probiotics do not always list the 18 strain names. In this study, we investigated the diversity of the bacteria and yeast sold in these products. 19
Introduction 37
A widespread awakening in the public and medical community's interest in commensal bacteria 38 for promoting health is currently underway. Accelerated by the ease and affordability of rapid DNA 39 sequencing technology, an avalanche of studies in animal models and humans has linked the 40 microorganisms living on or in the body to countless health conditions. In the decade since the Human 41
Microbiome Project was initiated to understand how microbes impact human physiology and disease 42 [1] , hundreds of studies are published each year exploring the roles of the microbiome (the microbial 43 community inhabiting the human body) in a wide range of diseases. The combination of impacts on 44 inflammation, immunity, nutrient metabolism, and even behavior may inextricably tie the healthy 45 balance vs. imbalance (dysbiosis) of the human gut microbiome to one's overall functioning as a healthy 46 human organism. While the composition of bacterial (and fungal, viral, and protozoan) residents of the 47 body is being mapped with increasing phylogenetic detail, many of the organisms are novel and the 48 biological functions of many of their genes remain unknown [2] . 49 This tidal wave of studies on the human microbiome has kindled renewed interest in the idea of 50 adding beneficial bacteria (probiotics) or foods that selectively enhance growth of certain beneficial 51 microbes (prebiotics) to the diet. Supplementing food with microorganisms is by no means new, with 52 fermented foods and beverages common in the diets of cultures around the world, yet mainstream 53 interest and market demand for probiotic foods is growing in parallel with research on the microbiome, 54 nutrition, and health [3] . The promoted advantage of probiotics is the maintenance or restoration of the 55 balance between pathogens and healthy necessary bacteria, via mechanisms such as binding to 56 pathogens, competition for nutrients, antimicrobial production, and modulating the immune system [4] . 57
In addition to their established roles in female reproductive health [5] , probiotics have been recognized 58 for myriad effects on digestive health [6] . 59 Obesity has been shown to be correlated with the microbiota, linked to an imbalance in energy 60 homeostasis, and probiotics and/or prebiotics show potential to address this [7] . According to Salazar et 61 al., prebiotic ingestion by obese women caused an increase in Bifidobacterium species, attenuated short-62 chain fatty acid (SCFA) production and thus abated metabolic factors correlated with obesity [8] . 63 Additionally, the consumption of probiotics has been demonstrated to improve insulin resistance 64 syndrome, type 2-diabetes and non-alcoholic fatty liver disease [6] . ADD_Science paper T2D. There is 65 evidence that probiotics assist with the production of vitamin B and necessary organic acids and amino 66 acids, with host absorption of vitamins and minerals, and with the production of enzymes such as 67 esterase, lipase and co-enzymes essential to metabolic processes [6] . The composition of the microbiota 68 is also associated with irritable bowel syndrome (IBS), a chronic disorder associated with abdominal 69 pain, distention and abnormal bowel movements, along with low grade inflammation and alterations to 70 the gut immune system [9] . Substantial evidence indicates the efficacy of specific probiotics for 71 alleviating the symptoms of IBS [10] . Other gastrointestinal disorders such as traveler's diarrhea [11] 72 and antibiotic-associated diarrhea [12] , have been shown to be treated or prevented with the 73 introduction of probiotics. 74
Still, the health claims made by many probiotic foods and supplements are often many steps 75 ahead of the science backing the studies. Despite a growing body of clinical trials supporting the specific 76 benefits of well-established strains [10] , more carefully designed and controlled studies are needed 77 [13] [14] . This gap between the advertised benefits of probiotics and the evidence to support their 78 efficacy, is due in part to the limited regulation on probiotic supplements, which are categorized by the 79 Food and Drug Administration (FDA) as food additives or ingredients rather than drugs. The microbial 80 strains they contain are classified as "GRAS" (generally recognized as safe), but the health claims on 81 packages are not verified by the FDA. With research on beneficial bacteria advancing rapidly, it is 82 expected that if the promise of microbiome-based therapies lives up to projections, then 'precision 83 probiotics' aiming to prevent or treat certain health conditions may soon be classified as drugs and 84 subjected to more stringent regulatory scrutiny and burden of proof for efficacy. Indeed, the end of the 85 2010s may represent the calm before the storm of 'next-generation probiotics' or 'bugs as drugs,' 86 discovered from research on healthy microbiomes, that could be used to treat specific diseases. 87
When probiotics are evaluated for their ability to treat specific conditions in clinical trials, the 88 strains used have demonstrated probiotic properties, yet the strain-level identity of probiotic bacteria is 89 not always provided on the ingredient label [15] . While in some cases probiotic properties are species-90 or genus-wide [16] , this omission raises several concerns, with safety being the foremost. Secondly, for 91 those brands that do not list the strain, it is possible that the included strain does not actually possess the 92 probiotic effects of clinically verified strains. Variability in cultivation and processing during probiotic 93 manufacturing, also raises the possibility that the integrity of the particular probiotic strain is lost over 94 time, through continuous passaging in industrial fermentations. When bacterial populations are cultured 95 repeatedly over time, new stable genetic populations can emerge, such as in ongoing experimental 96 evolution studies of Escherichia coli [17] and Burkholderia cenocepacia following repeated transfers of 97 the same starting population [18] . It is possible that this could occur after repeated passaging of fast-98 growing industrial microorganisms, perhaps selecting for better growth under industrial fermentation 99 conditions, and potentially leading to a reduction in their probiotic properties. 100 Identifying microbes at the strain level and ensuring that their beneficial properties are not lost 101 during the culturing and manufacturing process, is imperative for the live organisms to exert their 102 reported effect. The current study aimed to test how well routine genetic and phenotypic methods of 103 microbial identification could distinguish the microbes in common commercial probiotics at the species 104 and strain level, and to investigate the metabolic differences between the bacterial strains in each 105 product. Three approaches were used to identify each probiotic isolate: amplification and sequencing of 106 the 16S rRNA gene, Matrix Assisted Laser Desorption Ionization Time-of-Flight (MALDI-TOF) mass 107 spectrometry, and the Biolog Microbial Identification system, a 96-well plate multiplex phenotypic 108 assay consisting of 71 carbon source utilization tests and 23 chemical sensitivity tests [19] . We 109 hypothesized that comparing the phenotypic profiles of these common probiotics would reveal 110 differences in their nutrient metabolism (both across different probiotic species, and among strains of the 111 same species). We also explored the prevalence of certain types of bacteria in the marketplace and 112 compared this to the quantity of published research supporting their beneficial effects. 113
114
Methods 115
Isolation of bacteria from commercial probiotic products 116
Probiotic products were purchased in 2016-2017, opened within one month of the date of 117 purchase and bottles were stored at 4 °C. "Single-strain" probiotics contained only one species of live 118 microorganism, and "Multi-strain" probiotics contained two or more species listed on the label; however 119 only one isolated microbe was identified from each product. For those in capsule form, the capsule was 120 aseptically emptied into a microcentrifuge tube containing 1 ml of sterile water and mixed thoroughly. 121
Tablets were ground with a sterilized mortar and pestle and combined with sterile water. Probiotic 122 beverages were sampled using sterile swabs, directly from the original bottle. Using a sterile inoculating 123 loop, the sample was streaked for isolation onto the surface of the appropriate agar growth medium. For 124 culturing Lactobacillus species and Bacillus coagulans, MRS (de Man, Rogosa, and Sharpe) agar was 125 used, and TSA (Tryptic Soy Agar) was used for Bacillus subtilis. Yeast were cultured on SDA 126 (Sabouraud Dextrose Agar) or MRS. Agar plates were incubated at 30-33 °C for 48-72 hours 127 aerobically, and individual isolated colonies were identified. For single strain products, a well-isolated 128 colony was inoculated into liquid medium and incubated for 24 hours, then used to make a frozen 129 glycerol stock by mixing 700 µl of the overnight culture with 300 µl of sterile 50% glycerol (final 130 concentration 15% glycerol) and stored at -80 °C. For multi-strain products, one colony type was 131 selected, and re-streaked for isolation prior to storing as a frozen glycerol stock. 132
To observe cells from isolated colonies, isolated bacteria were Gram stained following the 133 standard procedure [20] and viewed under oil immersion with the 100x objective lens and photographed. 134
As a preliminary differentiation step between Lactobacillus and Bacillus, endospore staining was 135 performed on 1-week old cultures following the Schaeffer-Fulton procedure (Harley, 2017) . Heat fixed 136 smears were covered with a small piece of paper towel, and placed on a rack over a steaming water bath. 137
Malachite green dye (5%) was added on top of paper and heated for 5-7 minutes, adding fresh stain as 138 liquid evaporated. Slides were rinsed in water, counterstained with safranin for 1 minute, then viewed 139 under oil immersion with the 100x objective lens and photographed. Table S1 . Suspended cells were dispensed with an automatic multichannel 162 pipettor into the GenIII 96-well microplate (100 µl per well). The GenIII microplates were incubated at 163 33 °C for 16-48 hours and read using the MicroLog TM plate reader and associated software (Biolog, 164 Hayward, CA) once the positive control well A10 turned purple (typically at 20-24 hr of incubation). 165
Positive growth responses are indicated by a color change based on redox dye chemistry. Identification 166 is made by the GENIII MicroStation™ software, which compares the phenotypic fingerprint with a 167 fingerprint database of known bacteria [21] . Similarity (SIM) scores are assigned reflecting how well 168 the isolate matches the pattern in the database, and an identification is given if the SIM score is >0. 6. 169 Bacterial identifications and SIM scores were recorded, and the plate image was saved for later analysis. 170
The GenIII Microplate reference layout for each microorganism was also saved (see example in Figure  171 2D). The results from all Biolog plates were transcribed into a single summary table, using a "P" for 172 positive reaction wells (purple), representing growth and utilization of a carbon source . Wells scored by 173 the software as borderline (light color half-moon in Figure 2D , could be positive or negative) [21] were 174 recorded as "h" for half in the results tables. 175
For yeast, colonies grown for 48-72 hour on SDA were inoculated into 10 ml sterile water, and 176 the cell suspension was adjusted to 50% transmittance, then pipetted into the wells of a YT microplate. 177 YT plates were incubated at 26 °C for 24-72 hours, and analyzed at 24, 48, and 72 hours using the 178 MicroLog TM plate reader until an identification was made. Bacteria from frozen stock cultures were transferred to MRS or TSA plates and incubated at 30 0°C 205 for 48 hours prior to identification. Proteins were extracted using either the on-target method or by 206 using an ethanol-formic acid protocol described by Friewald & Sauer (2009). Cells from isolated 207 colonies were directly smeared onto a disposable FlexiMass™ DS target plate using a sterile toothpick. 208
One µl of 25% formic acid was added to the spot and allowed to air dry followed by the addition of 1 µl 209 of the α-Cyano-4-hydroxycinnamic acid (CHCA) matrix solution. The CHCA matrix solution contained 210 50 mg of CHCA dissolved in a 33/33/33 mixture of acetonitrile/ethanol/dH2O containing a final 211 concentration of 3% trifluoroacetic acid. When the on-target method yielded spectra with poor resolution, 212 proteins were extracted prior to spotting using ethanol and formic acid (Friewald & Sauer 2009). Cells 213 from colonies were dissolved in 300 µl of dH2O and inactivated by adding 900 µl of room temperature 214 absolute ethanol. The cell suspension was centrifuged twice at 10,000 x g for 2 minutes to remove the 215 supernatant. The pellet was air dried at room temperature for 1 minute and dissolved in 10 µl 70% 216 formic acid. Ten µl acetonitrile was added to the formic acid-cells mixture followed by centrifugation at 217 10,000 x g for 2 minutes at room temperature. The resulting supernatant containing extracted proteins 218 was transferred to a separate tube. One µl of the supernatant was spotted onto the target plate and 219 overlaid with 1 µl of the matrix. To estimate the percentage of products listing specific strains on the label, products were 233 evaluated from four marketplaces: a major online retailer, two drugstore chains, and a retail superstore 234 with brick-and-mortar store locations in Shelton, CT. A search for products from the online retailer was 235 conducted between Jan-April 2017 using the keyword "probiotic" and the name of the following 236 probiotic microbes: Bacillus coagulans, Bacillus subtilis, Lactobacillus acidophilus, Lactobacillus 237 plantarum, Lactobacillus rhamnosus, Bifidobacterium, and Saccharomyces boulardii. At least 20 238 products for each organism were checked, and if the label image contained a specific strain name or 239 number, this was recorded. For brick-and-mortar stores (visited in April 2018), we counted unique 240 products on the shelves in the probiotic section, examined the labels, and recorded the number of 241 products that listed at least one strain ID on the label. In stores in which a high volume of store-brand 242 generics was present, the products were only counted individually if the listed organisms were different 243 from another store-brand product. Note that products found on the shelves at multiple stores were tallied 244 each time in the count for that store; meaning that the list for each store often contained a high degree of 245 overlap (particularly of the most popular name-brand probiotics). The species identifications obtained by each method, for each isolate, are listed in Table 2 . Each 284 isolate was assigned a Code number to de-identify the product brand. Table 2 includes a total of 26 285 isolated organisms. For the S. boulardii probiotic yeast, the only method used was Biolog identification, 286 and two out of three products listing S. boulardii were correctly identified with the Biolog system. This 287 total exceeds the 18 total products listed in Table 1 , because it includes microbes for which the identity 288 was unknown prior to analysis (some probiotic yeasts, and environmental isolates from the Chaas 289 fermented beverage, fruit fly gut, and leaves). Seven of the products listed the specific strain 290 identification (Strain ID) on the label: B. coagulans GBI-30 6086 (patented as GanedenBc 30 ®), B. 291 subtilis DE111, L. plantarum 299V, L. rhamnosus GG, and L. rhamnosus LCR35 ( Table 2) . 292 293 
Identification by 16S rRNA gene sequencing 297
Molecular identification by sequencing the 16S rRNA gene is currently a routine method of 298 confirming species identity. The universal primers 27F and 1492R were used to amplify the near full 299 length 16S gene, using direct colony PCR. Since this gene sequence is generally not variable enough to 300 distinguish between strains of the same species, we used 16S rRNA sequencing primarily as a quality 301 control check to ensure that we had indeed isolated the correct species from each product. For those 302 products listing the Strain ID on the label, the top-scoring BLAST hit of the 16S sequence usually did 303 not match the exact strain name (with the exception of L. rhamnosus strain "GG."), and the % sequence 304 identity of the five top-scoring BLAST hits were typically identical (Table S2 ). In most cases, the 305 nucleotide BLAST search of the forward and the reverse sequences yielded different strain names of the 306 expected species (Table S2) . Several of the incorrect IDs (strain codes 7 and 8) may be attributed to 307 contamination during the procedure ( Table 2) . 308
309

MALDI-TOF identification 310 Using Matrix Assisted Laser Desorption Ionization Time of Flight Technology Mass 311
Spectroscopy (MALDI-TOF), the mass fingerprints of 15 bacteria isolated from commercial probiotics 312 or environmental sources were obtained and identified at the genus and species level. For 12 out of 18 313 isolated strains the MALDI identification matched that of the probiotic label (Tables 1+2). The "Chaas" 314 isolate was a homemade fermentation so the bacterial identity was not labelled; MALDI-TOF MS 315 identified this strain only on the genus level (Lactobacillus sp.). All Bacillus subtilis isolates were 316 correctly identified by MALDI-TOF MS. Bacillus coagulans strains were not as consistently identified 317 by this technique. The probiotic drink isolate (strain 14) was identified as Lactobacillus 318 pentous/plantarum, while the probiotic label indicated the strain was Bacillus coagulans. Bacillus 319 coagulans (strain 6) was misidentified by MALDI as B. subtilis. Several Lactobacillus strains were 320 unable to be identified: L. acidophilus, L. gasseri, and one L. plantarum (strain 11.) However, other L. 321 plantarum isolates were successfully identified so this species is represented in the SARAMIS database. 322 If a given peptide mass spectrum matched the database with a confidence score <75%, no identification 323 in SARAMIS could be reported; confidence interval scores are provided in Table S3 . 324 325
Biolog Identification & Phenotypic Profiling 326
Of the 18 probiotic bacterial isolates, 11 were correctly identified using the Biolog Microbial ID 327 system ( Table 1, Table 2 ). For 17 of these strains, the expected identity of the bacteria was given on the 328 product label, however the strain isolated from the "Chaas" fermented milk beverage was not known in 329 advance. Among the Lactobacillus isolates, Lactobacillus plantarum strains were the most amenable to 330 identification with the Biolog system. All of the L. plantarum strains isolated from probiotic products 331 were correctly identified, with SIM scores >0.6 (Table S1). One L. rhamnosus strain yielded an 332 incorrect identification, erroneously reading as Weissella viridescens. Neither L. acidophilus nor L. 333 gasseri were identified correctly with the Biolog assay. For the Bacillus strains isolated from probiotics, 334
Bacillus subtilis was more readily identified using the Biolog system. Three B. subtilis isolates from 335 different products were accurately identified, while none of the three B. coagulans isolates came up as 336 B. coagulans. Factors such as poor growth, use of non-optimal inoculating fluid or medium, or 337 inappropriate incubation conditions may have had adverse effects on the phenotypic expression pattern. 338
The time of incubation of the GenIII microplate is critical to a correct identification, as is the growth 339 medium. While the Biolog manufacturer recommends BUG-B agar, we observed better growth of B. 340 coagulans on MRS medium, so MRS was used. 341 Figure 2 summarizes the results from the Biolog phenotypic profiling for each strain, with 342 carbon source utilization patterns shown in Figure 2A and tolerance to environmental stressors (acidity, 343 salt, and various compounds) in Figure 2B . The reference pattern stored in the Biolog GenIII database is 344 displayed in the top row for each species. The darker color "P" wells indicate a strong positive, while the 345 lighter "h" wells indicate borderline results ( Figure 2D ); the preferred carbon sources are typically used 346 up more rapidly and completely, yielding a dark purple well, while less preferred substrates may be used 347 more slowly and incompletely [21] . Results of antibiotic susceptibility testing for 12 antibiotics using the 348 disc diffusion (Kirby-Bauer) method are also included in Figure 2 . Strain-specific differences were 349 observed for all of the species, in both carbon source utilization and environmental stress tolerance. 350
The Biolog system is also capable of identifying fungi such as yeast, using specific YT yeast 351 plates and the YT database. After optimizing the time and temperature (72 hours at 26 °C), we identified 352 yeast strains isolated from four probiotic drinks, one probiotic supplement and the surface of a kale leaf 353 with Biolog YT (Table 2, Figure 2C ). Three of these (strain codes 21, 22, 25) were labelled as 354 containing Saccharomyces boulardii, and the correct identification was obtained for two out of three. 355
The metabolic utilization patterns of 35 carbon sources were compared for these probiotic yeasts and 356 can be viewed in Figure 2C . The sugars glucose (Well D6/D7), turanose (Well A8), and maltose (A3) 357 had clear positive growth in the all S. boulardii isolates. Inulin (Well A12), a common prebiotic fiber, 358 was utilized by several strains, although the reference pattern for S. boulardii used in the Biolog 359 database is negative for inulin ( Figure 2C) . 360 361
Evaluation of product labels and quantification of published clinical studies 362
One objective of this project was to estimate the percentage of probiotic products currently on 363 the market that list the specific strain ID of the bacterial or yeast species on the ingredient label. 364
Products available from a major online retailer, at two drugstore chains, and at a retail superstore were 365 evaluated by reading the ingredient label and recording whether or not each product listed an 366 alphanumeric strain ID (often the patented name of the strain). Table 3 summarizes these product counts 367 from four retail sources. With this approximation we saw that an average of 49% (ranging from 34-69%) 368
of products contained specific strain information on the label. 369 370 To examine the number of clinical studies performed on these probiotic strains, providing 373 context for the amount of evidence supporting their health claims, we searched the biomedical literature 374 We isolated and cultured microbes from commercially available probiotic supplements and 385 beverages and used three approaches to identify the bacteria from these products. We then looked for 386 evidence of strain-level diversity between the isolates using phenotypic profiling. Sequencing of the 16S 387 gene and MALDI-TOF mass spectrometry both yielded accurate identifications for a higher percentage 388 of bacteria than the Biolog assay. Sequencing of the 16S rRNA gene has become a standard molecular 389 identification technique since its introduction in the 1980s [22] , but is generally not sufficient for strain 390 typing. MALDI-TOF mass spectrometry is a newer method for rapid identification of bacteria, however 391 it requires that the peptide mass spectra already exist in the database [23] . When comparing 16S 392 sequencing, Biolog identification, and other methods for identifying Lactobacillus species, only MALDI 393 mass spectrometry was noted for the ability to identify species at the subspecies, or strain level [24] . A 394 study on 148 strains of Lactobacillus species isolated from food found that the MALDI technique 395 generated accurate species identifications more often than 16S PCR (93% accuracy vs. 77% for PCR), 396 and the authors suggest that MALDI should be used in combination with genotypic methods for 397 improved reliability [25] . Sato and colleagues (2017) used MALDI-TOF and repetitive sequence based 398 PCR (rep-PCR) for rapid strain typing of strains of B. coagulans [26] . This group found a strong 399 correlation between these two methods to successfully distinguish between closely related strains, and 400 reported that carbohydrate utilization patterns correlated well with the MALDI and rep-PCR results for 401 some phylogenetic clusters [26] . We observed agreement in the results from the three methods, with 402 minor exceptions. For strain 1, MALDI and 16S results were in agreement, correctly identifying L. 403 rhamnosus ( Table 2) , but the Biolog identification of this isolate was Weissella viridescens, a lactic acid 404 bacterium (formerly classified as a Lactobacillus), often found in fermented foods [27] . Its pattern of 405 carbon source usage is quite similar to the other L. rhamnosus strains. For the "Chaas" isolate, 16S 406 sequencing identified this as L. casei, while Biolog suggested L. rhamnosus. These species are closely 407 related and belong to the L. casei group along with L. paracasei. 408
Several other molecular approaches have been used for distinguishing bacteria at the strain level, 409 such as multi-locus sequence typing (MLST), pulsed-field gel electrophoresis (PFGE), or amplified 410 fragment length polymorphism (AFLP). MLST used to be a "gold standard" for differentiating between 411 strains, however this is changing as costs of whole-genome sequencing (WGS) have decreased [28] . 412 PFGE and AFLP have been used to differentiate among probiotic strains of L. rhamnosus [29] and 413 L.plantarum isolated from various sources [30] . Ceapa and colleagues (2015) identified genotypic 414 clusters of L. rhamnosus with AFLP that correlated with functional metabolic clusters determined by 415
Biolog profiling [31] . Due to decreasing costs and improved efficiency, WGS is likely to be the future of 416 microbial strain typing [32] . Phylogenomics approaches have recently been proposed to improve the 417 classification of the diverse Lactobacillus genus [33, 34] , and metagenomic strategies with 418 bioinformatics analyses are in being developed to characterize microbial diversity at the subspecies level 419 in human microbiome communities [35] [36] . 420
Several studies have used comparative genomics to investigate the genetic basis of the probiotic 421 properties and predicted metabolic capabilities of these organisms. Khatri and colleagues compared 422 genomes of Bacillus coagulans to Bacillus subtilis, and found considerable genetic heterogeneity in B. 423 coagulans strains [37] , which has been recapitulated in carbohydrate utilization assays [26] . Analyzing 424 the genome of the commercialized B. coagulans strain HM-08 uncovered a xylose utilization gene 425 cluster, lending insight to future biotechnological applications for lactic acid production by this strain 426 [38] . Genome analysis has revolutionized the classification and characterization of lactic acid bacteria, 427 and functional genomics investigation has led to the discovery of novel processes of communication 428
with host cells, that may serve as models for understanding other host-microbe dynamics [39] . 429
Comparative genomics of Bifidobacterium species has unveiled substantial diversity carbohydrate 430 metabolism [40] and helped identify the cell surface proteins and exopolysaccharides used to colonize 431 the host intestine [41] . The wide range of polysaccharides used by B. longum species has been proposed 432 to aid in their success as early colonizers of the infant gut [42] . By comparing the genome of 433
Lactobacillus rhamnosus GG to a less-adherent starter culture strain, a unique genomic island encoding 434 secreted pilins that bind to human intestinal mucus was discovered [43] . These mucus-binding pilins 435 were shown to specifically outcompete vancomycin-resistant Enterococcus faecium (VRE) due to 436 homology in the binding site [44] . 437
Despite its lower performance to correctly identify probiotic bacteria, the Biolog 96-well plate 438 assay is a valuable tool for rapidly collecting phenotypic data on 71 carbon sources and 23 439 environmental stressors in one multiplex assay, and illustrates a critical link between prebiotics and 440 probiotics. By comparing the carbon source utilization patterns of the Lactobacillus and Bacillus 441 species, we can gain insight on shared and unique metabolic properties of these probiotic strains. The 442 most striking difference between the two Lactobacillus species compared to the Bacillus species, is their 443 overwhelming preference for sugars. Lactobacillus plantarum strains showed a very consistent pattern 444 of sugar utilization, with 14 sugar wells having a positive reaction for all five of the strains tested. These 445 results correlate with comparative functional genomics and metabolic profiling studies on L. plantarum 446 [30] [45] . L. plantarum probiotic strains, but not L. rhamnosus, utilized the complex polysaccharide, 447 pectin (Well F1), found in the skins of many fruits. This may be related to its prevalence in plant-448 associated habitats. Pectinolytic enzymes have been characterized in L. plantarum [46] and pectin 449 affects the probiotic phenotype of this species in vitro [47] . Likewise, L. plantarum grew on gentobiose 450 (Well A6), a rare disaccharide found in the gentian family of plants. Only L. rhamsosus utilized the 451 sugar rhamnose (Well C8). The antibiotic susceptibility profiles of L. rhamnosus vs. L. plantarum are 452 slightly different (Figure 2) . Like most lactobacilli, they are naturally resistant to vancomycin (Well 453 F10) due to absence of D-ala in the peptide crossbridge of their cell walls [48] , but L. plantarum strains 454 also displayed resistance to ciprofloxacin. The three L. rhamnosus strains tested were susceptible to 455 penicillin. 456
As a soil microbe subject to nutrient limitation in the environment, B. subtilis is known to be 457 much more versatile in its metabolism [49] , and this is reflected in its Biolog metabolic profiles. A 458 variety of amino acids are utilized, such as L-alanine (Well E3) and L-aspartic acid (Well E5) ( Figure  459 2A). These wells turned purple (positive) more rapidly than some of the sugar wells. B. subtilis is the 460 most salt-tolerant of the species investigated, growing at up to 8% NaCl (Well B12), but is more 461 susceptible to antibiotics than the lactobacilli (Figure 2B) . Bacillus coagulans, formerly classified as 462
Lactobacillus sporogenes and isolated from spoiled milk in 1915, inhabits ecological niches more 463 similar to lactic acid bacteria than other Bacillus spp. [50] . Although the Biolog approach did not 464 correctly identify the B. coagulans isolates, their pattern of carbon metabolism is primarily metabolizing 465 sugars, similar to the Lactobacillus species, and with the ability to withstand pH 5 (Well A12, Figure  466 2B). While B. coagulans is categorized as a "GRAS" ingredient, safety considerations are critical for 467 consumption of Bacillus subtilis [15] . It is unclear what the source of B. subtilis lacking Strain IDs are, 468 as the Biolog ID of strain 9 (from a single strain probiotic also containing plant extracts) resulted in the 469 same identification, Bacillus atrophaeus/subtilis, as the ID for a B. subtilis environmental isolate, which 470 we cultured from the surface of a leaf. The profile of this environmental B. subtilis was quite similar to 471 the strains from probiotic supplements, with the exception of utilization of quinic acid (well F8), a 472 compound found in plant sources. The spore-forming ability of Bacillus species makes them highly 473 stable probiotics that can be easily added to food or gummy supplements, however B. subtilis especially 474 merits increased regulation for safety and efficacy. 475
It is well known that strain-level differences occur in the probiotic properties of microorganisms 476 [51] . From survival in the GI tract (by tolerance to acidic pH and bile salts), to adhesive capacity to 477 intestinal cells, to competition with pathogens and production of bioactive compounds, the capacity and 478 efficiency to perform these functions is often strain-dependent [52] [53] . Here we show strain-level 479 differences in several environmental stressors, such as salt tolerance (Figure 2B, wells B10-B12) among 480 the Lactobacillus strains, and considerable variation in nutritional phenotypes, based on profiling of 481 carbon source usage. There is evidence that these two phenomena are related: the food sources and 482 molecular cues that microbes encounter in their environment affect their expression of proteins and 483 compounds (or community-level behavior such as aggregation and biofilm formation) that convey the 484 probiotic's beneficial effect. Further experiments are needed to measure a correlation between the 485 metabolic profiles and probiotic properties of these particular strains, similar to a study of two lactic acid 486 bacteria from the commercial culture FloraMax®-B11 [54] . Several examples of the relationship 487 between nutrient sources and bacterial probiotic phenotype include: increased resistance of L. plantarum 488 to gastric juices when growth with pectin or inulin compared to glucose [47] ; differences in cell surface 489 hydrophobicity, cell surface protein and exopolysaccharide production of L. rhamnosus grown on 490 fructose, mannose, or rhamnose [55] ; and increased the adhesion of Lactobacillus acidophilus to mucin 491 or intestinal cells in the presence of fructooligosaccharides (FOS), cellobiose, or polydextrose [56] . The 492 prebiotic cellobiose was shown to change surface layer proteins and increase auto-aggregation in two 493
Lactobacillus strains [57] . 494 A thorough understanding of the nutritional preferences of the commensal bacteria for current 495 and next-gen probiotics will be vital for their translation into effective products, and metabolic profiling 496 can help inform the design of "synbiotic" foods (containing probiotics and prebiotics) [58] [6] and 497 "biofunctional" foods (in which microorganisms cause the desired biological or physiological effect) 498 [51] . If end-products of microbial metabolism contribute to the health-promoting effect, it will be 499 imperative that the target microbes have an ample supply of and access to the carbon sources and 500 environmental signals that lead to synthesis of those end-products. For example, plant glucosides from 501 fruit are metabolized by L. acidophilus, which then secrete aglycones that exert beneficial effects on the 502 host [59] . Among the wide array of bioactive compounds produced by lactic acid bacteria are B 503 vitamins, gamma-aminobutyric acid (GABA), bioactive peptides, bacteriocins, and other complex 504 molecules such as exopolysaccharides [51] . Several other recent review articles summarize the health 505 benefits provided by microorganisms in functional foods [60] and explore the idea of how dietary 506 composition can reshape a healthy microbiome to restore functions lost through the Western diet and 507 lifestyle [61] [62] [7] . In a randomized clinical trial evaluating dietary interventions for type 2 diabetes 508 mellitus, a high fiber diet altered the composition of the gut microbiota, and greater diversity of 509 carbohydrates was associated with improved clinical outcomes [63] . The authors noted strain-specific 510 effects on which active SFCA-producing bacteria were positive responders to the fiber, such as certain 511 strains of Faecalibacterium prausnitzii [63] . 512
While traditional probiotic bacteria (lactobacilli and bifidobacteria) have been the subject of 513 research for decades, less is known about the preferred nutritional requirements of other dominant 514 members of the human gut microbiome. Using defined media, Tramontano and colleagues tested the 515 carbon source utilization of gut commensals (including mucin, carbohydrates, and the inhibition of 516 growth of some by amino acids or SCFAs [64] . 'Culturomics' studies combining MALDI-TOF 517 identification with >200 culture conditions optimized for fastidious growth have led to identification of 518 341 species of bacteria cultured from stool samples and helped optimize culture conditions for these 519 bacteria [65] . Better models to study the gut ecosystem are needed, to understand the context of the 520 metabolic interactions between gut commensals and probiotics. 521
In conclusion, there is currently a disparity between the composition of marketed probiotics 522 available to consumers and the science backing their claims (Figure 3) . In the food supplement industry, 523 the specific strain of a species is not always designated on the label, particularly for the generic, store-524 brand, or less-established brands. This may be due in part to proprietary restrictions. We found that on 525 average, roughly half of the probiotics examined had the specific strain listed on the label, which varied 526 considerably by store ( Table 3) . Regulatory guidelines differ widely across different countries [66] . 527 Probiotic labeling at the strain level is critical to so that consumers and/or healthcare providers can more 528 easily evaluate clinical studies of the probiotic's effects for specific indications [13] , even if these 529
properties are shared among all members of a species [16] . This study of common commercially 530 available probiotics highlights the importance of supporting health claims by correctly identifying the 531 microbes in probiotics, and the importance of understanding the ecophysiological needs of a given 532 microbe to enable its beneficial effect (e.g. competition, colonization, flocculation, biofilm, antibiotic 533 production, adhesion, bioactive metabolite production). In the complex milieu of the digestive tract, 534 metabolic profiling of individual microbes and microbial communities can help draw the link between 535 prebiotics, probiotics, and overall digestive health. These insights could bring about strategies for 536 optimizing health and wellness, grounded in nutrition that promotes synergy with our commensal 537 microbiota. 538 539 Acknowledgments 540
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